The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
Open accessAbstract
To investigate the contribution of IL-1, IL-6, and TNF to the increased osteoclastogenesis induced by estrogen deficiency, ovariectomized (ovx) mice were treated with either IL-1 receptor antagonist (IL-1ra), a competitive inhibitor of IL-1, TNF binding protein (TNFbp), an inhibitor of TNF, or the anti-IL-6 antibody (Ab) 20F3 for the first 2 wk after surgery. ovx increased the bone marrow cells secretion of IL-1 and TNF, but not IL-6, and the formation of TRAP-positive osteoclast-like multinucleated cells (MNCs) in bone marrow cultures treated with 1,25(OH)2D3. The increase in MNC formation induced by ovx was prevented by in vivo treatment with either 17 beta estradiol, IL-1ra, TNFbp, or anti-IL-6 Ab. However, the percent change in MNC formation induced by the anti-IL-6 Ab was similar in ovx and sham-operated animals, whereas IL-1ra and TNFbp were effective only in ovx mice. MNC formation was also decreased by in vitro treatment of bone marrow cultures with IL-1ra and TNFbp, but not with anti-IL-6 Ab. Ovx also increased bone resorption in vivo and in vitro, as assessed by the urinary excretion of pyridinoline cross links and the formation of resorption pits, respectively. IL-1ra, TNFbp and estrogen decreased bone resorption in vivo and in vitro whereas the anti-IL-6 Ab inhibited bone resorption in vitro but not in vivo. In conclusion, these data indicate that IL-1 and TNF play a direct role in mediating the effects of ovx on osteoclastogenesis and bone resorption. The data also suggest that IL-6 is not essential for increasing bone resorption in the early postovariectomy period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Evidence of Estrogen Receptors in Normal Human Osteoblast-Like Cells
Eriksen, E. F., Colvard, D. S., Berg, N. J., Graham, M. L., Mann, K. G., Spelsberg, T. C., & Riggs, B. L. (1988) · Science · doi:10.1126/science.3388021 · Cited by 1,229
Interleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
An interleukin 1 like factor stimulates bone resorption in vitro
Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B., & Russell, R. G. G. (1983) · Nature · doi:10.1038/306378a0 · Cited by 1,012
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
TAKAHASHI, N., YAMANA, H., YOSHIKI, S., ROODMAN, G. D., MUNDY, G. R., JONES, S. J., BOYDE, A., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-122-4-1373 · Cited by 730
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 679
Carter, D. B., Deibel, M. R., Dunn, C. J., Tomich, C.-S. C., Laborde, A. L., Slightom, J. L., Berger, A. E., Bienkowski, M. J., Sun, F. F., McEwan, R. N., et al. (1990) · Nature · doi:10.1038/344633a0 · Cited by 601
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
Arend, W. P., Welgus, H. G., Thompson, R. C., & Eisenberg, S. P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114622 · Cited by 581
Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E. R., Kurokawa, T., & Suda, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116179 · Cited by 577
Pacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
Self-citationThomson, B. M., Mundy, G. R., & Chambers, T. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.775 · Cited by 536
Local and Systemic Factors in the Pathogenesis of Osteoporosis
Epstein, F. H., & Raisz, L. G. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803313181305 · Cited by 493
Pfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Cytokines and Estrogen in Bone: Anti-Osteoporotic Effects
Horowitz, M. C. (1993) · Science · doi:10.1126/science.8480174 · Cited by 453
Uebelhart, D., Gineyts, E., Chapuy, M.-C., & Delmas, P. D. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90143-n · Cited by 424
Interleukin-11: a new cytokine critical for osteoclast development.
Girasole, G., Passeri, G., Jilka, R. L., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117130 · Cited by 399
Avian osteoclasts as estrogen target cells.
Oursler, M. J., Osdoby, P., Pyfferoen, J., Riggs, B. L., & Spelsberg, T. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6613 · Cited by 395
Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes.
Haskill, S., Johnson, C., Eierman, D., Becker, S., & Warren, K. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1690 · Cited by 393
Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts.
Thomson, B. M., Saklatvala, J., & Chambers, T. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.1.104 · Cited by 387
Sheehan, K. C. F., Ruddle, N. H., & Schreiber, R. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3884 · Cited by 379
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
Pacifici, R., Rifas, L., McCracken, R., Vered, I., McMurtry, C., Avioli, L. V., & Peck, W. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2398 · Cited by 375
Self-citationLöwik, C. W. G. M., van der Pluijm, G., Bloys, H., Hoekman, K., Bijvoet, O. L. M., Aarden, L. A., & Papapoulos, S. E. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90851-6 · Cited by 373
Effects of Interleukin-1 on Bone Turnover in Normal Mice*
BOYCE, B. F., AUFDEMORTE, T. B., GARRETT, I. R., YATES, A. J. P., & MUNDY, G. R. (1989) · Endocrinology · doi:10.1210/endo-125-3-1142 · Cited by 363
Kodama, H., Yamasaki, A., Nose, M., Niida, S., Ohgame, Y., Abe, M., Kumegawa, M., & Suda, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.269 · Cited by 356
Resorption of dentine by isolated osteoclasts in vitro
Boyde, A., Ali, N. N., & Jones, S. J. (1984) · British Dental Journal · doi:10.1038/sj.bdj.4805313 · Cited by 292
Perspectives: Interleukin-6: An osteotropic factor?
Roodman, G. D. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070502 · Cited by 272
Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction.
Yin, T., Taga, T., Tsang, M. L., Yasukawa, K., Kishimoto, T., & Yang, Y. C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2555 · Cited by 262
Interleukin-1β is a potent inhibitor of bone formation in vitro
Dr. Stashenko, P., Dewhirst, F. E., Rooney, M. L., Desjardins, L. A., & Heeley, J. D. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020612 · Cited by 255
Immunoassay for urinary pyridinoline: The new marker of bone resorption
Seyedin, S. M., Kung, V. T., Daniloff, Y. N., Hesley, R. P., Gomez, B., Nielsen, L. A., Rosen, H. N., & Zuk, R. F. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080515 · Cited by 242
Self-citationInterleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.
Kimble, R. B., Vannice, J. L., Bloedow, D. C., Thompson, R. C., Hopfer, W., Kung, V. T., Brownfield, C., & Pacifici, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117187 · Cited by 233
Self-citationRalston, S. H., Russell, R. G. G., & Gowen, M. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050912 · Cited by 231
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice.
Sabatini, M., Boyce, B., Aufdemorte, T., Bonewald, L., & Mundy, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5235 · Cited by 216
An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties.
Arend, W. P., Joslin, F. G., Thompson, R. C., & Hannum, C. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1851 · Cited by 206
Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
Passeri, G. (1993) · Endocrinology · doi:10.1210/en.133.2.822 · Cited by 186
National Institutes of Health Consensus Conference.
Fink, M. (1985) · PubMed · Cited by 180
Role of colony-stimulating factors in osteoclast development
Takahashi, N., Udagawa, N., Akatsu, T., Tanaka, H., Shionome, M., & Dr. Suda, T. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060912 · Cited by 178
Ralston, S. H. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090614 · Cited by 174
TAKAHASHI, N., AKATSU, T., SASAKI, T., NICHOLSON, G. C., MOSELEY, J. M., JOHN MARTIN, T., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-123-3-1504 · Cited by 168
Regulation of interleukin 1 gene expression by adherence and lipopolysaccharide.
Fuhlbrigge, R. C., Chaplin, D., Kíely, J.-M., & Unanue, E. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.11.3799 · Cited by 164
Chaudhary, L. R. (1992) · Endocrinology · doi:10.1210/en.130.5.2528 · Cited by 162
Seckinger, P., Klein‐Nulend, J., Alander, C., Thompson, R. C., Dayer, J. M., & Raisz, L. G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4181 · Cited by 154
Lorenzo, J., Sousa, S., Alander, C. B., Raisz, L. G., & Dinarello, C. A. (1987) · Endocrinology · doi:10.1210/endo-121-3-1164 · Cited by 134
Cohen-Solal, M. E., Graulet, A. M., Denne, M. A., Guéris, J., Baylink, D. J., & de Vernejoul, M. C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8263153 · Cited by 128
Bellido, T., Girasole, G., Passeri, G., Yu, X. P., Mocharla, H., Jilka, R. L., Notides, A. C., & Manolagas, S. C. (1993) · Endocrinology · doi:10.1210/endo.133.2.8393768 · Cited by 105
Felix, R., Fleisch, H. A., & Elford, P. R. (1989) · Calcified Tissue International · doi:10.1007/bf02556317 · Cited by 95
van der Pluijm, G., Most, W., van der Wee-Pals, L. J. A., de Groot, H., Papapoulos, S. E., & Löwik, C. W. G. M. (1991) · Endocrinology · doi:10.1210/endo-129-3-1596 · Cited by 91
Rickard, D. J., Russell, R. G. G., & Gowen, M. (1992) · Osteoporosis International · doi:10.1007/bf01623843 · Cited by 83
Estrogen modulation of avian osteoclast lysosomal gene expression
Oursler, M. J., Pederson, L. G., Pyfferoen, J., Osdoby, P., Fitzpatrick, L. A., & Spelsberg, T. C. (1993) · Endocrinology · doi:10.1210/endo.132.3.8440193 · Cited by 73
Is there a causal role for IL-1 in postmenopausal bone loss?
Pacifici, R. (1992) · Calcified Tissue International · doi:10.1007/bf00301625 · Cited by 70
Self-citationLerner, U. H., & Ohlin, A. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080205 · Cited by 69
Hustmyer, F. G., Walker, E., Yu, X., Girasole, G., SAKAGAMI, Y., Peacock, M., & Manolagas, S. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080108 · Cited by 52
92238400 Increased osteoclast development after estrogen loss: Mediation by interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1993) · Maturitas · doi:10.1016/0378-5122(93)90156-c · Cited by 48
Pacifici, R., Brown, C., Puscheck, E. E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1992) · Maturitas · doi:10.1016/0378-5122(92)90077-h · Cited by 46
Self-citationFalkenburg, J. H. F., Harrington, M., Paus, R., Walsh, W., Daub, R., Landegent, J. E., & Broxmeyer, H. (1991) · Blood · doi:10.1182/blood.v78.3.658.658 · Cited by 45
Pioli, G., Basini, G., Pedrazzoni, M., Musetti, G., Ulietti, V., Bresciani, D., Villa, P., Bacchi, A., Hughe, D., Russell, R. G. G., et al. (1992) · Clinical Science · doi:10.1042/cs0830503 · Cited by 42
Cytokine production by peripheral blood cells in postmenopausal osteoporosis
Zarrabeitia, M. T., Riancho, J. A., Amado, J., Napal, J. J., & González-Macı́as, J. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90093-f · Cited by 39
Yamada, H., Iwase, S., Mohri, M., & Kufe, D. W. (1991) · Blood · doi:10.1182/blood.v78.8.1988.1988 · Cited by 38
Malyak, M., Joslin, F. G., Verderber, E. L., Eisenberg, S. P., & Arend, W. P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90381-o · Cited by 38
Fiore, C. E., Falcidia, E., Foti, R., Motta, M., & Tamburino, C. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80039-6 · Cited by 26
Matsuda, T., Matsui, K., Shimakoshi, Y., Aida, Y., & Hukuda, S. (1991) · Calcified Tissue International · doi:10.1007/bf02555851 · Cited by 19
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Metadata
- Authors
- Kitazawa, R., Kimble, R. B., Vannice, J. L., Kung, V. T., & Pacifici, R.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-12-01
- Volume
- 94
- Issue
- 6
- Pages
- 2397-2406
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2126446849
- Cited by
- 336
- References
- 67
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.